A Common Medication With Important Long-Term Considerations
Proton pump inhibitors (PPIs) — including omeprazole (Prilosec), esomeprazole (Nexium), pantoprazole (Protonix), lansoprazole (Prevacid), and rabeprazole — are among the most prescribed medications in the world. They are highly effective for acid-related conditions and remarkably safe in short-term use.
The trouble is that many patients take PPIs for years or decades, often without a clear ongoing indication. Long-term use carries real risks that deserve discussion. At Zimmer Medical Group, we regularly help patients evaluate whether continued PPI use is necessary and, when appropriate, taper safely.
When PPIs Are Clearly Indicated Long-Term
Several conditions have strong evidence for indefinite or long-term PPI therapy:
- Erosive esophagitis that has healed with PPI therapy
- Barrett's esophagus
- Severe GERD that recurs immediately when PPIs are stopped — see our GERD vs. heart attack article for symptom comparison
- History of bleeding ulcer (peptic ulcer disease)
- Zollinger-Ellison syndrome (gastrin-secreting tumor)
- Chronic NSAID use in patients at high risk of ulcers
- Eosinophilic esophagitis (in some patients)
- High-dose prevention in patients on dual antiplatelet therapy with risk factors
For these patients, the benefit of continued therapy clearly outweighs the risks.
When PPIs Often Get Continued Without Clear Indication
Many patients end up on long-term PPIs through pathways like:
- Started in the hospital for stress ulcer prophylaxis and never stopped
- Started for vague "indigestion" or non-ulcer dyspepsia
- Continued years after H. pylori was successfully treated
- Started during an NSAID course that was discontinued long ago
- Started for mild reflux that could be managed with lifestyle measures
These patients deserve a re-evaluation: is the original indication still present, and could lifestyle measures or step-down therapy work?
Real Risks of Long-Term Use
Several risks have substantial supporting evidence:
Vitamin B12 Deficiency
PPIs reduce gastric acid, which is needed to release vitamin B12 from food proteins. Long-term use can cause B12 deficiency, particularly in older adults. Periodic checking is reasonable for patients on PPIs for more than 2 years.
Magnesium Deficiency
Long-term PPI use can cause significant hypomagnesemia, sometimes requiring IV repletion. Symptoms include muscle cramping, fatigue, arrhythmias, and seizures in severe cases. Annual magnesium checks are reasonable for long-term users.
Bone Fractures
PPIs are associated with a modest increase in hip, wrist, and spine fractures. The mechanism likely involves reduced calcium absorption and possibly direct effects on bone. The risk is most pronounced in patients with other osteoporosis risk factors.
C. difficile Infection
Acid suppression allows C. diff to survive passage through the stomach more easily. Long-term PPI use modestly increases C. diff infection risk, particularly in patients also receiving antibiotics.
Pneumonia
Some studies show modestly increased rates of community-acquired pneumonia in PPI users, possibly through bacterial overgrowth in the upper GI tract.
Kidney Effects
Long-term PPI use is associated with a modest increase in chronic kidney disease and acute interstitial nephritis. The absolute risk is small but real.
Iron Deficiency
Acid is helpful for iron absorption. Long-term PPI users — particularly menstruating women, vegetarians, and those with marginal intake — may develop iron deficiency. See our iron deficiency in women guide.
Risks That Are Likely Overstated
Some publicized risks have weaker evidence:
- Dementia: Initial concerning studies have not been consistently confirmed; the relationship is uncertain
- Heart attack risk: Largely refuted by subsequent research
- Most cancers: No clear evidence of causation, though associations exist with some upper GI cancers (likely confounded)
It is reasonable to take a balanced view: PPIs are not innocuous, but they are not dangerous medications either when used appropriately.
Lifestyle Measures Often Underused
Before settling for indefinite PPI therapy for mild GERD, several measures help substantially:
- Weight loss in patients with overweight or obesity
- Avoiding meals within 3 hours of bedtime
- Elevating the head of the bed by 6–8 inches (or using a wedge)
- Avoiding personal trigger foods — common triggers include alcohol, chocolate, peppermint, very fatty meals, citrus, tomato-based foods, and caffeine
- Smaller, more frequent meals
- Smoking cessation
- Reducing alcohol intake
These measures alone control mild reflux for many patients.
How to Deprescribe Safely
Stopping PPIs cold turkey often causes rebound acid hypersecretion — temporarily worse symptoms that can be mistaken for the original problem returning. A planned approach reduces this:
Step 1: Assess Whether Continued Therapy Is Needed
For patients on PPIs for non-essential indications:
- Confirm there is no history of bleeding ulcer, severe esophagitis, or Barrett's esophagus
- Confirm symptoms are mild and well-controlled
- Discuss the goal of trying to reduce or stop
Step 2: Step Down Before Stopping
Several effective approaches:
- Reduce from twice daily to once daily for 2–4 weeks
- Switch from daily to every other day for 2–4 weeks
- Switch to an H2 blocker (famotidine) which can be tapered more easily
- Use as-needed PPI rather than daily
Step 3: Anticipate Rebound
A short period of worse symptoms when stopping is normal — typically 2–4 weeks — and does not necessarily mean the underlying disease is uncontrolled. Antacids (Tums, Maalox), an H2 blocker as needed, or alginates (Gaviscon) can manage this transition.
Step 4: Have a Plan for Recurrence
If symptoms return:
- Try lifestyle modifications first
- Use as-needed therapy (H2 blocker or PPI)
- Restart daily PPI only if needed and if specific indications justify it
Special Situations
Patients with Frequent NSAID Use
If you take regular NSAIDs and have ulcer risk factors (older age, prior ulcer, anticoagulant use, high NSAID dose), continued PPI therapy may remain appropriate.
Older Adults on Multiple Medications
Long-term PPI use should be a specific topic during medication reviews — see our article on polypharmacy.
Patients with Atypical or Concerning Symptoms
Symptoms like difficulty swallowing, food getting stuck, unintentional weight loss, persistent vomiting, blood in stool, or new severe heartburn after age 50 warrant endoscopic evaluation rather than continued empirical PPI therapy.
When to See Your Doctor
- You have been on a PPI for over a year and have not discussed whether to continue
- New or worsening symptoms despite PPI therapy
- Difficulty swallowing, weight loss, or other concerning features
- Considering trying to come off your PPI
- Need to address vitamin or mineral deficiencies that may be related
The American Gastroenterological Association clinical practice guidelines provide additional detailed recommendations on PPI deprescribing.
On long-term acid-reducing medication and uncertain whether you still need it? Contact Zimmer Medical Group for a thoughtful review and a safe deprescribing plan when appropriate.
